RT @TomerHertz@twitter.com
Some stories end well, and I am happy to tell you one short one from our lab. Recently, I tweeted about my frustrating experience with trying to publish our methods paper in @FrontImmunol@twitter.com: https://twitter.com/TomerHertz/status/1599363419844808706. 1/5
🐦🔗: https://twitter.com/TomerHertz/status/1607668687049486338
Welp
This broke my brain
Cyclosporine A as a vaccine adjuvant to induce TRegs is something that would never have occurred to me, let alone it leading to *enhanced* antibody responses
RT @johnprensner
Do you think you know how your favorite proteins start? With an ATG?
You better look carefully before making that assumption!
Great work by @Triasteran in @NatureComms
@cyrilpedia interesting!
last boost (#LB?): LOVED Carolyn @bertozzi's answer when asked for whether her winning the Nobel Prize provides "an enhanced platform" to address gender issues in STEM (at time 22:00): "It's probably a question that's better posed to the men around the table...there are so many more of them and they are in a position to make change that's 9 times greater than my own position." 🙌🏽🙌🏽🙌🏽
Our new must-read Nature paper: Inheritance of paternal DNA damage by repair restriction
We resolve one of the most long standing riddles in radiation biology: What are the heritable consequences of paternal radiation exposure? @CECAD @UniKoeln @dfg_public Find the answer here:
https://www.nature.com/articles/s41586-022-05544-w
What's the best way to debunk a misleading graph? 📊
A new study suggests that providing an "accurate alternative" is most effective.
Misleading graphs can omit baselines to exaggerate differences and cherry-pick sections of data to hide greater trends. The other methods tested included providing a warning arrow pointing to the issue or an educational or general text warning next to the graph.
https://doi.org/10.22323/2.21070207
#SciComm #ResearchIntegrity #Misinformation #Science @academicchatter
I made a few terrific friends on the bird site, but with the dislodging of the #covid #misinformation policy, the recent amplification of nutcases (who degrade #scicomm), I hope more scientist colleagues can share findings/thoughts/interesting papers here. #science #fediverse #twittermigration
ICYMI: Inhibition of translation termination by Drosocin, an antimicrobial peptide from fruit flies.
https://www.biorxiv.org/content/10.1101/2022.12.11.519952v1
Key result, the authors find mutations in Drosocin that improve its ribosomal inhibitory activity, suggesting it could be improved further.
My latest clinical pipeline column for Nature Medicine is a look at a drug recently approved by the #FDA to delay the onset of type 1 diabetes.
It's a direct descendant of the very first monoclonal ever approved for clinical use.
#Diabetes #Type1Diabetes #DrugDevelopment #DrugDiscovery #NatureMedicine #Immunology #MonoclonalAntibody
With Twitter in tumult, @stokel@twitter.com looks at its influence on science communication, and what researchers will do next. Some are sticking it out on the site, others have already left.
https://www.nature.com/articles/d41586-022-04506-6
RT @globalimmuno@twitter.com
We are delighted to share the new #globalimmuno talks flyer for the first half of 2023.
Check out the amazing organizers and the fabulous line of speakers!
All info also in https://www.globalimmunotalks.org/
Please help us spread the word🙏
🐦🔗: https://twitter.com/globalimmuno/status/1603207580314062848
The genetic and ecological landscape of plasmids in the human gut
https://www.biorxiv.org/content/10.1101/2020.11.01.361691v4?ct=
We preprinted a revised version of work by Carrie Zhu and colleagues, taking a new approach to understand sex differences in genetic effects on complex traits. Below are some of the revision highlights.
The Bel Lab, boldly going where no one else bothers to.
@ERC_Research
funded lab. Former
@LHooperLab
postdoc. Opinions are my microbiota's. #NewPI